U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 217873
Company: STERISCIENCE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE 100MG/5ML (20MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription AP No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/09/2024 ORIG-1 Approval STANDARD

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/08/2026 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

SUCCINYLCHOLINE CHLORIDE

SOLUTION;INTRAMUSCULAR, INTRAVENOUS; 100MG/5ML (20MG/ML)
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE 100MG/5ML (20MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 218467 DR REDDYS
SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE 100MG/5ML (20MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 217884 FRESENIUS KABI USA
SUCCINYLCHOLINE CHLORIDE SUCCINYLCHOLINE CHLORIDE 100MG/5ML (20MG/ML) SOLUTION;INTRAMUSCULAR, INTRAVENOUS Prescription No AP 217873 STERISCIENCE
Back to Top